Literature DB >> 19747583

Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients.

S G Gao1, K H Li, K B Zeng, M Tu, M Xu, G H Lei.   

Abstract

OBJECTIVE: To investigate osteopontin (OPN) levels in both synovial fluid and articular cartilage of patients with primary knee osteoarthritis (OA) and their relationship with severity of the disease.
METHOD: Fifty patients aged 48-81 years with knee OA and 10 healthy controls were enrolled in this study. Anteroposterior knee radiographs or/and Mankin score were taken to determine the disease severity of the affected knee. The radiographic grading of OA in the knee was performed by using the Kellgren-Lawrence criteria. OPN levels in synovial fluid were measured using enzyme-linked immunosorbent assay. OPN levels in articular cartilage were assessed by immunohistochemical methods.
RESULTS: Compared to healthy controls, OA patients had higher OPN concentration in synovial fluid (4519.60+/-1830.37, 95%CI 3999.42-5039.79 vs 1179.70+/-303.39, 95%CI 1035.53-1438.74 pg/ml, P<0.001)and articular cartilage(0.6+/-0.06, 95%CI 0.59-0.62 vs 0.43+/-0.07, 95%CI 0.38-0.48, P<0.01). In addition, synovial fluid OPN levels showed a positive correlation with articular cartilage OPN levels (r=0.411, 95%CI 0.150-0.619, P=0.003). Subsequent analysis showed that synovial fluid OPN levels significantly correlated with severity of disease (Spearman's rho=0.581, 95%CI 0.335-0.726, P<0.001). Furthermore, the articular cartilage levels of OPN also correlated with disease severity (Spearman's rho=0.675, 95%CI 0.500-0.808, P<0.001).
CONCLUSIONS: OPN in synovial fluid and articular cartilage is associated with progressive joint damage and is likely to be a useful biomarker for determining disease severity and progression in knee OA. Crown Copyright 2009. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747583     DOI: 10.1016/j.joca.2009.07.009

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  43 in total

1.  Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis.

Authors:  Hye-In Ji; Sang-Hoon Lee; Ran Song; Hyung-In Yang; Yeon-Ah Lee; Seung-Jae Hong; Somi Kim; Yong-Beom Park; Soo-Kon Lee; Myung Chul Yoo; Kyoung Soo Kim
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

Review 2.  Role of integrins and their ligands in osteoarthritic cartilage.

Authors:  Jian Tian; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2014-09-27       Impact factor: 2.631

3.  Distribution of small integrin-binding ligand, N-linked glycoproteins (SIBLING) in the articular cartilage of the rat femoral head.

Authors:  Yao Sun; Su Ma; Jin Zhou; Albert K Yamoah; Jian Q Feng; Robert J Hinton; Chunlin Qin
Journal:  J Histochem Cytochem       Date:  2010-08-02       Impact factor: 2.479

4.  The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee.

Authors:  Fang-Jie Zhang; Shu-Guang Gao; Ling Cheng; Jian Tian; Wen-Shuo Xu; Wei Luo; Yang Song; Yang Yang; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

5.  Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes.

Authors:  Shu-Guang Gao; Yang Yu; Chao Zeng; Shi-Tao Lu; Jian Tian; Chao Cheng; Liang-Jun Li; Guang-Hua Lei
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

6.  Roles of microRNA-539 and osteopontin in rheumatoid arthritis.

Authors:  Yan Liu; Kai Qian; Chunmei Li; Yi Ma; Xingguo Chen
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

7.  Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes.

Authors:  Feng Ding; Jing Wang; Guoxiong Zhu; Huaqiang Zhao; Gaoyi Wu; Lei Chen
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

8.  Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.

Authors:  Shu-Guang Gao; Chao Zeng; Yang Song; Jian Tian; Chao Cheng; Tuo Yang; Hui Li; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

9.  Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.

Authors:  Iman H Bassyouni; Mohammed M El-Wakd; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

Review 10.  Association of osteopontin with osteoarthritis.

Authors:  Chao Cheng; Shuguang Gao; Guanghua Lei
Journal:  Rheumatol Int       Date:  2014-05-08       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.